1181324

Pfizer, Inc. — FEI 3003836868

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 28, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Parsippany, NJ (United States)